Prestige Wealth Management Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Prestige Wealth Management Group’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-159	Closed	-$18.4K	–	1087
2023 Q3	$18.4K	Hold	159	–	–	﹤0.01%	343
2023 Q2	$16.4K	Hold	159	–	–	﹤0.01%	386
2023 Q1	$17.4K	Sell	159 -43	-21%	-$4.75K	﹤0.01%	354
2022 Q4	$23K	Sell	202 -107	-35%	-$8.89K	0.01%	338
2022 Q3	$19K	Buy	309 +70	+29%	+$4.89K	0.01%	331
2022 Q2	$19K	Buy	239 +36	+18%	+$3.41K	0.01%	341
2022 Q1	$22K	Sell	203 -14	-6%	-$1.36K	0.01%	335
2021 Q4	$24K	Sell	217 -63	-23%	-$6.87K	0.01%	356
2021 Q3	$30K	Sell	280 -99	-26%	-$10.3K	0.01%	314
2021 Q2	$35K	Buy	379 +79	+26%	+$7.27K	0.01%	280
2021 Q1	$28K	Hold	300	–	–	0.01%	310
2020 Q4	$22K	Hold	300	–	–	0.01%	344
2020 Q3	$23K	Hold	300	–	–	0.01%	327
2020 Q2	$17K	Hold	300	–	–	0.01%	359
2020 Q1	$9K	Buy	300 +100	+50%	+$3.38K	﹤0.01%	406
2019 Q4	$7K	Hold	200	–	–	﹤0.01%	396
2019 Q3	$5K	Hold	200	–	–	﹤0.01%	427
2019 Q2	$5K	Buy	+200	New	+$5.07K	﹤0.01%	406

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Prestige Wealth Management Group's HZNP Position: Q4 2023 in Review

Prestige Wealth Management Group sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 159 shares — an estimated $18.4K sold.

Prestige Wealth Management Group first reported a position in HZNP in Q2 2019 and held it in 18 quarters. The position peaked at $35K in Q2 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Prestige Wealth Management Group reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Prestige Wealth Management Group sold 159 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $18.4K.
Prestige Wealth Management Group first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2019 and held it in 18 quarters.
Prestige Wealth Management Group's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $35K in Q2 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Prestige Wealth Management Group's 13F filing for Q4 2023, filed 8 Feb 2024.